The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Is The Therapeutic BCG Vaccines Market’s Market Value Anticipated To Evolve From 2026 To 2030?
The therapeutic BCG vaccines market has experienced substantial expansion in recent years. It is projected to increase from $59.09 billion in 2025 to $62.77 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 6.2%. This historical growth can be ascribed to elements such as high tuberculosis prevalence, growing research in immunotherapy, restricted vaccination coverage, various government health initiatives, and enhanced awareness of BCG’s benefits.
The therapeutic bcg vaccines market is projected for robust expansion in the coming years, with its size set to reach $80.4 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 6.4%. This anticipated growth during the forecast period is driven by factors such as the increasing demand for personalized vaccines, technological advancements in vaccine delivery, a heightened focus on immuno-oncology applications, the expansion of public health initiatives, and growing investment in biotech innovations. Key developments expected over this period include the evolution of personalized bcg therapy, innovations in vaccine delivery, expanded research in TB immunotherapy, the use of combination therapies with bcg, and government-funded immunization programs.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9178&type=smp
What Primary Factors Are Fueling The Expansion Of The Therapeutic BCG Vaccines Market?
The increasing global incidence of tuberculosis (TB) is set to drive the expansion of the therapeutic BCG vaccine market in the future. TB is a contagious and potentially hazardous disease, primarily affecting the lungs, and spreads person-to-person through airborne bacterial droplets released during coughing or sneezing. BCG vaccines work by stimulating the immune system to combat infection without causing TB, as they contain weakened germs. These vaccines consistently provide protection against severe forms of TB, such as adolescent TB meningitis, thus leading to increased therapeutic usage. For instance, a February 2024 report from the UK Health Security Agency, a UK government body, indicated a 10.7% rise in tuberculosis (TB) cases in England in 2023, reaching 4,850 reported cases compared to 4,380 in 2022. Consequently, the global rise in tuberculosis (TB) cases is fueling the expansion of the therapeutic BCG vaccine market.
How Is Segment Classification Applied In The Therapeutic BCG Vaccines Market?
The therapeutic bcg vaccines market covered in this report is segmented –
1) By Type: Therapy BCG, Other Types
2) By Demographics: Pediatrics, Adults
3) By End Use: Hospitals, Clinics, Other End Users
What Trends Are Impacting The Therapeutic BCG Vaccines Market?
Major companies in the therapeutic BCG vaccine market are concentrating on developing innovative vaccines for potential therapeutic uses across various medical conditions, such as BCG immunotherapy, to expand their customer base and address growing patient requirements. BCG (Bacillus Calmette-Guérin) immunotherapy refers to the application of the BCG vaccine as a form of immunotherapy for treating specific types of cancer, particularly bladder cancer. For instance, in July 2023, The Serum Institute of India, an India-based biotechnology and biopharmaceuticals company, obtained government approval to export its BCG vaccine to Canada for immunotherapeutic use in combating bladder cancer. This live freeze-dried formulation, derived from an attenuated strain of Mycobacterium bovis (Bacillus Calmette Guerin), is intended for intravenous instillation. The vaccine is available in 40 mg and 80 mg presentations. As a vital part of the therapy, the vaccine is administered directly into the bladder through a catheter, where it resides in the bladder lining for a predetermined duration. This targeted strategy aims to effectively impact cancer cells while minimizing effects on other body parts.
Who Are The Leading Firms Participating In The Therapeutic BCG Vaccines Market?
Major companies operating in the therapeutic bcg vaccines market are Merck & Co Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute of India Pvt. Ltd., InterVax Ltd., Statens Serum Institute, AJ Vaccines, Bul Bio-National Center of Infectious and Parasitic Diseases Ltd, Biomed Lublin S.A., PT Bio Farma, Torlak Institute of Virology, Bacille Bilie Calmette-Guerin Laboratory, Bharat Biotech International Ltd., Shanghai Institute of Biological Products Co. Ltd., Instituto Butantan, BioCen, Panacea Biotec Ltd., Institute Pasteur de Tunis, Korean BCG Vaccine Institute
Access The Complete Therapeutic BCG Vaccines Market Report:
https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report
Which Region Stands As The Largest Contributor To The Therapeutic BCG Vaccines Market?
Asia-Pacific was the largest region in the therapeutic BCG vaccines market in 2025. The regions covered in the therapeutic bcg vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Therapeutic BCG Vaccines Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=9178&type=smp
Browse Through More Reports Similar to the Global Therapeutic BCG Vaccines Market 2026, By The Business Research Company
Therapeutic Bcg Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report
Therapeutic Bcg Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report
Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model